growth hormone releasing hormone ; Homo sapiens

19 Article(s)
Pub. Year
#Total Relationships
1 34599040 Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone-Inhibitory Effect of Octreotide after Growth Hormone-Releasing Hormone Stimulation. 2021 Dec 1
2 20379782 Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy. 2012 Jun 2
3 22539587 Oral octreotide absorption in human subjects: comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppression. 2012 Jul 1
4 19017754 Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies. 2009 Feb 4
5 17373589 Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment. 2007 1
6 17541749 Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients. 2007 1
7 15356066 Activation of somatostatin-receptor subtype-2/-5 suppresses the mass, frequency, and irregularity of growth hormone (GH)-releasing peptide-2-stimulated GH secretion in men. 2004 Sep 2
8 11155087 No advantage of the new combined octreotide-GHRH test over established GH-stimulation tests in the diagnosis of growth hormone deficiency (GHD) in adults. 2000 Dec 2
9 8675565 Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency. 1996 Jul 1
10 8740200 The attenuated inhibitory action of octreotide, a somatostatin analogue on GHRH-induced growth hormone response in type I diabetes mellitus. 1996 Apr 1
11 7581949 Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion. 1995 Sep 2
12 7962343 Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and alpha-subunit-secreting tumors from acromegalic patients responsive to octreotide. 1994 Nov 3
13 8187302 Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects. 1994 Mar 6
14 1518441 Potential indications for octreotide in endocrinology. 1992 Sep 2
15 1521513 Ectopic acromegaly. 1992 Sep 2
16 1839344 Progestins and growth hormone excess in the dog. 1991 1
17 2493033 Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion. 1989 Feb 6
18 2506217 The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-releasing hormone, thyrotropin, and GH in man. 1989 Oct 2
19 2899089 Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor. 1988 Aug 2